APA Citatie

Matheson, E. C., Thomas, H., Case, M., Blair, H., Jackson, R. K., Masic, D., . . . Irving, J. A. (2019). Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM. Haematologica.

Chicago Style citaat

Matheson, Elizabeth C., et al. "Glucocorticoids and Selumetinib Are Highly Synergistic in RAS Pathway-mutated Childhood Acute Lymphoblastic Leukemia Through Upregulation of BIM." Haematologica 2019.

MLA citatie

Matheson, Elizabeth C., et al. "Glucocorticoids and Selumetinib Are Highly Synergistic in RAS Pathway-mutated Childhood Acute Lymphoblastic Leukemia Through Upregulation of BIM." Haematologica 2019.